Limited Coverage Drugs - indacaterol

Generic Name

indacaterol

Strength

75 mcg

Form

dry powder for oral inhalation

Special Authority Criteria

Approval Period

Diagnosis of chronic obstructive pulmonary disease (COPD) defined where a spirometry measure is:

  • A post-bronchodilator fixed ratio of forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) < 0.70

AND

Contraindication or intolerance to a long-acting muscarinic receptor antagonist (LAMA)

AND

Dosage does not exceed 75 mcg per day.

Indefinite

Practitioner Exemptions

  • Respirologists are not required to submit a Special Authority request form for coverage.

Special Notes

  • In remote areas, where spirometry access is limited, spirometry measurements are to be provided within 6 months.

Special Authority Request Form